trial · primary record
Allogeneic stem cell transplant
Leukemia, B-cell
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 85 |
| Primary completion | 2024-04-02 |
| Primary endpoint | To assess the safety of allogeneic anti-CD19 CAR |
| Registry ID | NCT01087294 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:24.126Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01087294
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.